ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy. Alzforum, 30 Jul 2016 Marco-Contelles J, Unzeta M, Bolea I, Esteban G, Ramsay RR, Romero A, Martínez-Murillo R, Carreiras MC, Ismaili L.